Tropomyosin 3 pseudogene 2 (TPM3P2)

Tropomyosin 3 pseudogene 2 (TPM3P2) is classified as a pseudogene, meaning it is a non-functional genomic element derived from a functional gene (TPM3) through duplication or retrotransposition events. It does not encode a functional protein and is not involved in biological processes, disease mechanisms, or drug interactions. TPM3P2 is listed under chromosome 20 and included in gene databases as a non-coding pseudogene. The related functional gene, Tropomyosin 3 (TPM3), encodes an actin-binding protein involved in muscle contraction and cytoskeletal stability, but TPM3P2 itself does not have those properties[4][5][6]. TPM3P2 is not considered a therapeutic target. It does not participate in signaling or regulatory functions and is not associated with diseases or biomarkers. The query is partially incorrect: TPM3P2 is often confused with its parent gene TPM3, which is biologically active and involved in muscle disorders and cancer. However, TPM3P2 has no known physiological or pathological roles. TPM3P2 is also named TPM5P and dJ1125A11.2 in various genetic databases[4][5]. It is categorized as a pseudogene, with no protein product or associated pathways[4][5][6]. For structured data, TPM3P2 should be distinguished from TPM3, the functional form. TPM3 (not TPM3P2) is the true target relevant for physiological and pathological studies.

Other names

TPM5PdJ1125A11.2